LRRK2 and Parkinson disease: Using the same technique, more than 200 urine samples from different groups of subjects were analyzed, including (i) healthy controls, (ii) non-manifest carriers of the LRRK2 G2019S mutation, (iii) idiopathic PD patients, and (iv) manifest PD patients with LRRK2 G2019S.